Alliance management – Engaged with licensing partner organizations and internal stakeholders to manage governance processes and led cross functional teams to develop strategic responses to partnership and program challenges Corporate strategy – Managed competitive intelligence and maintained executive-level visibility on progress and challenges with partner and internal development programsBusiness development – Engaged potential partners in collaboration ideation, terms negotiation and due diligence activities

Key Responsibilities • Licensing – Engage with senior leadership in business development and scientific teams within multinational pharmaceutical companies to promote licensing discussions• Strategy – Conduct primary and secondary research, or leverage professional service firms, to conduct opportunity sizing, competitive analysis, and product positioning projects that support licensing activities and strategic decisions

• Led new in licensing initiatives for pharmaceutical products originated in the Americas region for China market entry by prioritizing and selecting target products through qualitative screening processes, conducted China market and competitive analyses to scope opportunity sizes and engaged with potential licensing partners in initial outreach, negotiations and due diligence on potential products• Managed existing relationships with North American partners by liaising with regulatory, legal, sales, marketing and commercial teams to develop and deliver regular reporting cycles to members of partners' senior leadership, developed strategies solving regulatory challenges and leveraging new internal capabilities and managed collaborative activities such as joint trainings

Select Strategy Experience:• Forecasted the market opportunity for a novel drug in four Asian markets with potential peak sales nearing $80m by modeling data from epidemiology and market access research• Developed new business models for an MNC drug distributor in China, potentially increasing revenue by 300% in 5 years by shifting from specialty medications to pharmacy solutions SelectM&A Experience:• Supported the APAC region in the global integration of two medical device companies by tracking synergies of $21.3m and identifying $1.8m in additional synergies• Defined optimized headcount targets for the supporting functions of an MNC pharma company in China based on benchmarking data and deep-dive interviews

• Supported a listed biotech company focusing on radio-immunology through fund-raising events by maintaining and presenting financial models, drafting investor presentation materials and facilitating a leadership transition • Refined investment strategies for a cross-boarder healthcare and clean energy venture capital fund by conducting historical performance analysis, market research and in depth conversations with senior leadership• Developed client-ready legal and marketing materials for fund-raising activities, including market analysis, data presentation and presentation coaching

Biotech Direct Investing Experience:• Executed direct investing activities for the FoF portfolio and underlying portfolio funds by: maintaining an observer seat on a board of directors of an Asia-focused therapeutics drug development company; conducting due diligence; drafting internal proposals. Also engaged Chinese counterparts in strategic discussion, deal execution and investment syndication• Spearheaded China-focused and cross-border initiatives for portfolio companies by providing strategic advisory, identifying and engaging strategic partners, investment targets and investors in ChinaBiotech Fund of Funds Management Experience:• Supported management of four biotech funds of funds with $75m in AUM: including financial projections, internal reporting, investor communications and interfacing with fund and portfolio company managers• Completed $9m of commitments to four funds: including due diligence and historical performance analysis

• Developed strategic, organizational recommendations to reduce and structure a $30mil/yr spend category • Interfaced with senior-level, internal clients and suppliers to gather information and present findings• Conducted a comprehensive market review as well as analyses of data from disparate, internal sources

• Launched first legal and physical corporate presence overseas by establishing a representative office in Shanghai• Supervised all logistical, fiscal and legal aspects of the China office with an annual budget of $400,000• Doubled Chinese sourcing capacity by identifying, engaging, and negotiating contracts with new suppliers• Increased sales to China by 50% by acquiring new customers and engaging new markets through market research and networking• Created a quality control team: hired, trained, and managed a staff of three, and created policies and procedures for a quality control system• Directed suppliers in the process to become compliant with new quality and safety regulations imposed by the United States government

• Developed project and training proposals for the Lan-Cang Jiang Economic Development Commission.• Edited and negotiated international trade contracts.• Translated and edited economic reports issued by the LCC to ADB and other major financial institutions.

• Developed and delivered cultural and English as a Foreign Language courses at Yunnan University for classes as large as 300+ students• Reported on modern trends in culture, politics and economics for semi-annual publication • Liaised between Yunnan University and Oberlin-Shansi Memorial Association during transitional period

• Organized and mobilized teams of Chinese peer educators ranging from 10 to 15 people through frequent meetings and personal contact to improve job performance• Developed new procedural policies to increase accountability of peer educators and instated feedback mechanisms for constant improvement of educational programming • Rebuilt customer database providing valuable performance metrics• Capitalized on rich cross-cultural knowledge to facilitate communication and mutual understanding between Chinese and English-speaking parts of the organization